Mainstream

Vertex Pharmaceuticals Non-GAAP EPS of $4.52 beats by $0.27, revenue of $2.96B beats by $50M

Vertex Pharmaceuticals Non-GAAP EPS of $4.52 beats by $0.27, revenue of $2.96B beats by $50M

Post ContentvrtxRead More

You might also be interested in reading Japan approves bill to classify crypto as financial instruments.

August 4, 2025
In Mainstream